Categories: Technology

Altai Announces Dismissal of Its Claim by Quebec Court

 | Source: Altai Resources Inc.

TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) — Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that, further to the Company’s news release dated September 5, 2025, in connection with the Company’s claim filed in the Superior Court of Quebec (the “Court”) in 2022 (the “Claim”) against the Ministry of Energy and Natural Resources (Quebec), the Government of Quebec, as represented by the Attorney General of Quebec, and the Attorney General of Quebec (collectively, the “Defendants”), seeking compensatory damages from the Defendants for the expropriation in 2022 of the Company’s oil and gas exploration assets in Quebec (the “Expropriation”), the Court has notified the Company that it has granted, at the request of the Attorney General of Quebec, the dismissal of the Claim on the grounds that the Company no longer has legal representation.

ABOUT THE COMPANY
Altai Resources Inc. is a Toronto, Ontario based resource company with an oil property in Alberta and a Canadian investment portfolio comprised of cash and cash equivalents. Additional information about the Company is available on SEDAR+ at www.sedarplus.ca and on the Company’s website at www.altairesources.com.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This news release contains certain statements by the Company that constitute forward-looking statements (the “Forward-Looking Statements”). Forward-Looking Statements are based on material factors, expectations, or assumptions that have been used by the Company to develop such statements, but which may prove to be incorrect. Although the Company believes that the expectations reflected in these Forward-Looking Statements are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Since Forward-Looking Statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Further, events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control. The reader is cautioned not to place undue reliance on these Forward-Looking Statements. The Forward-Looking Statements contained in this news release are made as of the date hereof and the Company undertakes no obligations to update publicly or to revise any Forward-Looking Statements, whether as a result of new information, future events, or otherwise, unless so required by applicable securities laws.

For further information, please contact:
Kursat Kacira, Chairman & CEO/President
T: (647) 282-8324, E: kursatkacira@altairesources.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

GlobeNews Wire

Recent Posts

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus As Nature Intended, Ingredients

NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS, AND MENTAL CLARITY…

2 hours ago

Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness

New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED AS A NEW…

2 hours ago

Sugar Clean Drops: Top Blood Sugar Support Supplement for Metabolic Wellness and Energy Support

SUGAR CLEAN DROPS ANNOUNCED AS A NEW SUPPLEMENT SUPPORTING HEALTHY BLOOD SUGAR AND METABOLIC WELLNESS…

2 hours ago

DBV Technologies Announces 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the…

13 hours ago

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:15 ET  | Source: Zenas BioPharma WALTHAM, Mass., Jan. 16, 2026 (GLOBE…

13 hours ago